Indian Journal of Pharmaceutical Education and Research logo
Submit
Indian Journal of Pharmaceutical Education and ResearchAn Official Publication of Association of Pharmaceutical Teachers of India (APTI)
Article

Evaluation of in-vitro Immunomodulatory Activity and Thrombolytic Potential of Kabasura Kudineer (KSK): An Official Siddha Polyherbal Formulation

1, 1, 2, 3, 4, 4

  1. 1Siddha Central Research Institute, Chennai, Tamil Nadu, INDIA
  2. 2National Centre for Nanoscience’s and Nanotechnology, University of Mumbai, Vidyanagari, Santa Cruz (E), Kalina Campus, Mumbai, Maharashtra, INDIA.
  3. 3Central Council for Research in Siddha, Ministry of AYUSH, Chennai, Tamil Nadu, INDIA.
  4. 4Research and Development Centre, Salem Microbes Private Ltd., Salem, Tamil Nadu, INDIA.

CORRESPONDENCE

Dr. M. S. Shree Devi

Siddha Central Research Institute, Chennai, Tamil Nadu, INDIA

shreemd@gmail.com

Received: 02-01-2021; Accepted: 02-06-2021.

Volume 55, Issue 3 · pp. 774-781 · 2021 · DOI: 10.5530/ijper.55.3.150

ABSTRACT

Aim: Coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), attacking mainly on the immune system of a body. This has spread mortality and morbidity all over the world. During this dreadful situation there is an urgent need for the development and rapid dissemination of COVID-19 treatment. Siddha’s traditional medicine system can be used as preventive care to boost the immune system.Materials and Methods: The immense treasure of knowledge found in Siddha medicine can help mortality. Kabasura Kudineer (KSK) is one of the Siddha poly herbal formulation used as an immune-boosting agent against several diseases.Results: In the present study the KSK has been investigated for its effects of immunomodulatory and thrombolytic potential. The KSK at the concentrations of 12.5, 25, 50, and 100 µg/ml showed % immune-stimulations of 12.40 %, 20.81, 33.53, and 43.20 and for NBT showed 19.00, 25.50, 64.00, 71.00 % respectively. Moreover, similarly, the thrombolytic activity showed 50, and 100 µg/ml concentration showed 43.83 %, 71.83 % clot lysis, respectively, and the control value for the Streptokinase showed 83.78 %.Conclusion: Hence, it can be confirmed that KSK has immunomodulatory and thrombolytic properties in vitro models. Immunomodulatory and anti-thrombolytic are the steps to create a stable, safe, and efficient COVID-19 cure.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Parameswaran, S., Ramulu, S. D. M. S., Arivarasan, V. K., Kadarkarai, K., Dhanakoti, R. K., & Loganathan, K. (2021). Evaluation of in-vitro Immunomodulatory Activity and Thrombolytic Potential of Kabasura Kudineer (KSK): An Official Siddha Polyherbal Formulation. Indian Journal of Pharmaceutical Education and Research, 55(3), 774-781. https://doi.org/10.5530/ijper.55.3.150

    Copyright and licence

    © 2021 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0